Friday, April 3

IRVINE, CALIFORNIA – A medical practitioner in California is now facing both criminal prosecution and a significant civil lawsuit following the death of a newborn during what was supposed to be a routine circumcision procedure. The case has sparked outrage and renewed calls for stricter oversight of paediatric surgical practices. 

A Tragic Discovery

The incident occurred when the infant’s parents returned home following the procedure. According to court filings, the parents found their baby “cold to the touch and not breathing” during the overnight hours. Despite rushing the child to a nearby hospital, he was pronounced dead the following morning. 

Toxicology Findings and Legal Ramifications

Subsequent toxicology reports revealed the death was caused by acute Demerol intoxication, rather than the local anesthetic originally reported. The Orange County coroner confirmed high levels of the potent narcotic in the infant’s system, leading to a charge of involuntary manslaughter against the doctor. Irvine Police described the event as a “negligent and preventable” tragedy. 

Ongoing Legal Action

Alongside the criminal case, the family has initiated a civil malpractice lawsuit. The doctor, who has pleaded not guilty and is due back in court on May 1, 2026, has had their medical license suspended. This incident, which echoes other high-profile surgical negligence cases, highlights severe risks to patient safety.

Share.
Leave A Reply

Doctors Post is a news portal tailored to provide current news & updates on issues related exclusively to medical & healthcare professionals. The content of Doctor Post is judiciously authored by a dedicated team of legal experts, doctors and reporters.  The intent of the content is to expeditiously update doctor’s information & news necessary for the smooth functioning of their profession.

© 2024 Doctor Post. All Rights Reserved. Created and Maintained by Creative web Solution

Disclaimer: Use of the site is governed by our terms of use, privacy policy, and advertisement policy. For further details, please refer to our Disclaimer.

Exit mobile version